Moleculin Biotech (MBRX) has shared an announcement.
Moleculin Biotech, Inc. announced that its abstract will be presented at the EHA2024 Hybrid Congress from June 13-16 in Madrid and online. This event could provide the company an opportunity to showcase its latest research to a wide audience, potentially impacting its visibility and credibility within the biotech and investment communities.
See more insights into MBRX stock on TipRanks’ Stock Analysis page.
